Diagnosis and treatment of chronic insomnia
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Insomnia is a disorder characterized by inability to sleep or a total lack of sleep, prevalence of which ranges from 10 to 15% among the general population with increased rates seen among older ages, female gender, White population and presence of medical or psychiatric illness. Yet this condition is still under-recognized, under-diagnosed, and under-treated. This article aims to review the operational definitions and management of chronic insomnia. A computerized search on PubMed carried from 1980 to January 2009 led to the summarization of the results. There are several strategies to manage chronic insomnia. To initiate treatment, it is necessary to define it and differentiate it from other co-morbid psychiatric disorders. Non-pharmacologic strategies such as stimulus control therapy and relaxation and cognitive therapies have the best effect sizes followed by sleep restriction, paradoxical intention and sleep hygiene education which have modest to less than modest effect sizes. Among pharmacotherapeutic agents, non-benzodiazepine hypnotics are the first line of management followed by benzodiazepines, amitryptiline and antihistaminics. However, adequate trials of combined behavior therapy and pharmacotherapy are the best course of management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943
A behavioral perspective on insomnia treatment
Spielman, A. J., Caruso, L. S., & Glovinsky, P. B. (1987) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30532-x · Cited by 1,261
Recommendations for a standard research assessment of insomnia
Buysse, D. J., Ancoli-Israel, S., Edinger, J. D., Lichstein, K. L., & Morin, C. M. (2006) · Sleep · doi:10.1093/sleep/29.9.1155 · Cited by 1,206 · cited 1×
“The treating clinician should have a high index of suspicion of insomnia or sleep difficulty when patients present with the following symptoms:[19] fatigue, excessive daytime sleepiness, major and/or minor depressive episode, generalized anxiety disorder, memory/concentration complaints, pain.”
MORIN, C., LEBLANC, M., DALEY, M., GREGOIRE, J., & MERETTE, C. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.08.008 · Cited by 1,191 · cited 1×
“[9,10] Despite these high prevalence rates, evidence suggests that insomnia is mostly under-recognized, under-diagnosed, and under-treated,[4] with the condition continuing to remain persistent in 50–85% of individuals over follow-up intervals of one to several years.[11]”
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1172 · Cited by 1,098 · cited 3×
“06 for wake aft er sleep onset.[31,32] As is the premise for most self-management skills, all these relaxation techniques require regular practice over a period of several weeks, and professional guidance is oft en necessary in the initial stage of training.”
Nonpharmacologic Treatment of Chronic Insomnia
Morin, C. M., Hauri, P. J., Espie, C. A., Spielman, A. J., Buysse, D. J., & Bootzin, R. R. (1999) · Sleep · doi:10.1093/sleep/22.8.1134 · Cited by 888
Franzen, P. L., & Buysse, D. J. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/plfranzen · Cited by 747
Identifying effective psychological treatments for insomnia: A meta-analysis.
Murtagh, D. R. R., & Greenwood, K. M. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.63.1.79 · Cited by 664
Effects of exogenous melatonin on sleep: a meta-analysis
Brzezinski, A., Vangel, M. G., Wurtman, R. J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2004.06.004 · Cited by 541
Irwin, M. R., Cole, J. C., & Nicassio, P. M. (2006) · Health Psychology · doi:10.1037/0278-6133.25.1.3 · Cited by 537
Riemann, D., & Perlis, M. L. (2009) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2008.06.001 · Cited by 477 · cited 2×
“In combination with behavioral therapy, it however, yields the most durable improvements in sleep patt erns.[42]”
Medical and socio-professional impact of insomnia
Léger, D., Guilleminault, C., Bader, G., Lévy, E., & Paillard, M. (2002) · Sleep · doi:10.1093/sleep/25.6.621 · Cited by 468 · cited 1×
“[12,13] There is also an increased risk for depression, anxiety, substance use, suicide, and possible immune dysfunction.”
Insomnia as a Health Risk Factor
Taylor, D. J., Lichstein, K. L., & Durrence, H. H. (2003) · Behavioral Sleep Medicine · doi:10.1207/s15402010bsm0104_5 · Cited by 450
Valerian for Sleep: A Systematic Review and Meta-Analysis
Bent, S., Padula, A., Moore, D., Patterson, M., & Mehling, W. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.026 · Cited by 387 · cited 1×
“Valerian appears to be well tolerated; however, it can cause headache and daytime sedation[63] and is currently still being evaluated.[64]”
Holm, K. J., & Goa, K. L. (2000) · Drugs · doi:10.2165/00003495-200059040-00014 · Cited by 317
A Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia
Mendelson, W. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0409 · Cited by 308
Practice Parameters for the Nonpharmacologic Treatment of Chronic Insomnia
Chesson, A. L., Anderson, W. M., Littner, M., Davila, D., Hartse, K., Johnson, S., Wise, M., & Rafecas, J. (1999) · Sleep · doi:10.1093/sleep/22.8.1128 · Cited by 264
A systematic review of non-pharmacological therapies for sleep problems in later life
Montgomery, P. (2004) · Sleep Medicine Reviews · doi:10.1016/s1087-0792(03)00026-1 · Cited by 260 · cited 2×
“However, Montgomery and Dennis[41] reviewed p sychological/behavioral and other non-pharmacologic strategies in a similar population and observed minimal changes in sleep latency (mean decrease: 3 minutes) and modest eff ects on wake aft er sleep onset (mean decrease: 22 minutes) and total sleep time (mean increase: 1…”
InfluentialKnowledge and practice of sleep hygiene techniques in insomniacs and good sleepers
Lacks, P., & Rotert, M. (1986) · Behaviour Research and Therapy · doi:10.1016/0005-7967(86)90197-x · Cited by 209 · cited 1×
“, light, noise, temperature, and matt ress) that may be either detrimental or benefi cial to sleep.[38] Although these factors are rarely severe enough to be the primary cause of chronic insomnia, they may complicate an existing sleep problem and hinder treatment progress.”
Hajak, G., Rodenbeck, A., Voderholzer, U., Riemann, D., Cohrs, S., Hohagen, F., Berger, M., & Ruther, E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0609 · Cited by 199 · cited 1×
“Evidence for their effi cacy when used alone is relatively weak and hence no specifi c agent within this group is recommended as preferable to the others in this group.[58-61]”
Winokur, A., DeMartinis, N. A., McNally, D. P., Gary, E. M., Cormier, J. L., & Gary, K. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1013 · Cited by 165 · cited 1×
“Evidence for their effi cacy when used alone is relatively weak and hence no specifi c agent within this group is recommended as preferable to the others in this group.[58-61]”
Oral Nonprescription Treatment for Insomnia: An Evaluation of Products With Limited Evidence
Meoli, A. L., Rosen, C., Kristo, D., Kohrman, M., Gooneratne, N., Aguillard, R. N., Fayle, R., Troell, R., Townsend, D., Claman, D., et al. (2005) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26314 · Cited by 152 · cited 1×
“[65] Melatonin and l-tryptophan are two other molecules undergoing evaluation for the treatment of chronic insomnia.[66] There is currently very litt le evidence for their use.”
Trimipramine in Primary Insomnia: Results of a Polysomnographic Double-Blind Controlled Study
Riemann, D., Voderholzer, U., Cohrs, S., Rodenbeck, A., Hajak, G., Rüther, E., Wiegand, M. H., Laakmann, G., Baghai, T., Fischer, W., et al. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-34119 · Cited by 145
Holbrook, A., Crowther, R., Lotter, A., & Endeshaw, Y. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49161.x · Cited by 61
Benefit-Risk Assessment of Zaleplon in the Treatment of Insomnia
Barbera, J., & Shapiro, C. (2005) · Drug Safety · doi:10.2165/00002018-200528040-00003 · Cited by 51 · cited 1×
“No specifi c agent within this group is recommended as preferable to the others in a general sense; each has been shown to have posi tive eff ects on sleep latency, total sleep time (TST), and/or wake aft er sleep onset (WASO) in placebo-controlled trials.[52-55]”
Cited by
Lederman, O., Ward, P. B., Firth, J., Maloney, C., Carney, R., Vancampfort, D., Stubbs, B., Kalucy, M., & Rosenbaum, S. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.11.004 · Cited by 128
Farah, N. M., Saw Yee, T., & Mohd Rasdi, H. F. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16234750 · Cited by 99
Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease?
Grandner, M. A. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2014.911148 · Cited by 88
Zakiei, A., Khazaie, H., Rostampour, M., Lemola, S., Esmaeili, M., Dürsteler, K., Brühl, A., Sadeghi-Bahmani, D., & Brand, S. (2021) · Life · doi:10.3390/life11020133 · Cited by 84
Dalrymple, K. L., Fiorentino, L., Politi, M. C., & Posner, D. (2010) · Journal of Contemporary Psychotherapy · doi:10.1007/s10879-010-9145-1 · Cited by 58
Metadata
- Authors
- Saddichha, S.
- Venue
- Annals of Indian Academy of Neurology
- Publisher
- Medknow
- Published
- 2010
- Volume
- 13
- Issue
- 2
- Pages
- 94
- ISSN
- 0972-2327 (ISSN-L)
- OpenAlex
- W1983392743
- Cited by
- 128
- References
- 25
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.